COMMUNIQUÉS West-GlobeNewswire

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
11/11/2025
WALTHAM, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
11/11/2025
FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management [...]
Flower by Edie Parker Announces Exclusive Partnership with Verano to Launch Cannabis Line in Florida with Campaign Starring Miami Native and Grammy-Nominated Rapper JT
11/11/2025
NEW YORK, NY, & CHICAGO, IL, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Edie Parker (the “Company”), a leading female founded, female operated lifestyle brand merging the worlds of fashion and cannabis, today announced an [...]
Solésence Reports Third Quarter 2025 Financial Results
11/11/2025
Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in [...]
New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans
11/11/2025
Prospective study data and retrospective registry data were analyzed in the manuscripts recently published by the Journal of Cataract and Refractive Surgery, Journal of Glaucoma and Clinical Ophthalmology MENLO PARK, [...]
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
11/11/2025
REDWOOD CITY, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
11/11/2025
Confirms Receipt of Unsolicited Indication of Interest and Director Nominations from Lynx1 Master Fund LP No Stockholder Action Required at This Time BURLINGTON, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Neuphoria [...]
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
11/11/2025
Conference call will be held today, Tuesday, November 11 at 9:00 am ET CARMEL, Ind., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company [...]
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
11/11/2025
Sanjeev Luther, President and CEO to give an oral presentation and participate in a moderated panel discussion CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry [...]
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
11/11/2025
AC Immune to Present at the Jefferies 2025 London Healthcare Conference Lausanne, Switzerland, November 11, 2025 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision [...]
RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening
11/11/2025
Acquisition supplements CIMAR’s cloud-native infrastructure with DeepHealth’s AI-powered informatics to deliver connected, efficient and accessible care LOS ANGELES and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- RadNet, [...]
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology
11/11/2025
MILPITAS, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Applied StemCell, Inc. (ASC), today announced the successful knock-in of a 50 kilobase (kb) multifunctional DNA insert into human induced pluripotent stem cells (iPSCs [...]
Coloplast A/S - Notice of Annual General Meeting 2025
11/11/2025
Notice of Annual General Meeting 2025 The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen [...]
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma
11/11/2025
225Ac-SSO110 has received U.S. FDA Orphan Drug Designation Initial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026 Potential to address a broad range of neuroendocrine cancers BERLIN, Nov. 11, 2025 ( [...]
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
11/11/2025
BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the pricing of an [...]
Canadian Red Cross sending emergency medical clinic to Jamaica
11/11/2025
Humanitarian experts deploying to help people impacted by Hurricane Melissa OTTAWA, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- In response to the devastating impact of Hurricane Melissa across the Caribbean region, the [...]
La Croix-Rouge canadienne déploie une clinique médicale d’urgence en Jamaïque
11/11/2025
Des spécialistes humanitaires sont mobilisés pour porter secours aux personnes touchées par l’ouragan Melissa OTTAWA, Ontario, 10 nov. 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne, en collaboration avec la [...]
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
11/11/2025
TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based [...]
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/11/2025
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]

Pages